SCHEMBL6319251

SCHEMBL6319251

Cc1[nH]c2ccc(C(=O)O)cc2c1Cc1ccc(COC2CCCCC2)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.52
POLB P06746 2/20 0.44
KDM4E B2RXH2 4/20 0.41
PSMD14 O00487 1/20 0.41
RECQL P46063 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
APEX1 P27695 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
THRB P10828 1/20 0.41
RAB9A P51151 1/20 0.39
SCN9A Q15858 1/20 0.38
TBXAS1 P24557 1/20 0.37
LMNA P02545 1/20 0.36
IDH1 O75874 1/20 0.36
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MMP3 P08254 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6319665 0.91 KDM4E (0.46) PTPN5POLBKDM4EALDH1A1HPGD
SCHEMBL6318663 0.83 SCN9A (0.40) PTPN5POLBRAB9ASCN9APPARG
SCHEMBL6319864 0.82 PTPN5 (0.58) PTPN5POLBKDM4EPSMD14RECQL
SCHEMBL6319268 0.81 PTPN5 (0.52) PTPN5POLBKDM4EPSMD14RECQL
SCHEMBL5881620 0.79 PTPN5 (0.57) PTPN5POLBKDM4EPSMD14RECQL
SCHEMBL6326442 0.77 PTPN5 (0.55) PTPN5POLBKDM4EPSMD14RECQL
SCHEMBL5881650 0.77 PTPN5 (0.55) PTPN5POLBKDM4EPSMD14RECQL
SCHEMBL6325273 0.77 PTPN5 (0.58) PTPN5POLBKDM4EPSMD14RECQL
SCHEMBL6322652 0.76 POLB (0.61) PTPN5POLBKDM4EPSMD14RECQL
SCHEMBL5881790 0.76 PTPN5 (0.58) PTPN5POLBKDM4EPSMD14RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171185-A1 Indole derivatives FUJISAWA PHARMACEUTICAL CO., LTD., A JAPANESE CORPORATION 2005-08-04 US disclosed
US-20050025795-A1 Compounds, Compositions and methods for insect control THE PROCTER & GAMBLE COMPANY (US) 2005-02-03 US disclosed
EP-1501830-A1 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES Actelion Pharmaceuticals Ltd. (CH) 2005-02-02 EP disclosed
EP-1397042-A1 COMPOSITIONS AND METHODS FOR INSECT CONTROL THE PROCTER & GAMBLE COMPANY (US) 2004-03-17 EP disclosed
WO-2003093267-A1 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES ACTELION PHARMACEUTICALS LTD (CH) 2003-11-13 WO disclosed
WO-2002067680-A1 COMPOSITIONS AND METHODS FOR INSECT CONTROL THE PROCTER & GAMBLE COMPANY (US) 2002-09-06 WO disclosed
EP-1070705-A1 INDOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050025795-A1 Compounds, Compositions and methods for insect control PWWP2B, CUTA, WAPL PTPN5 441/4885POLB 1565/4885KDM4E 1659/4885
US-20050171185-A1 Indole derivatives PDE5A, IGFBP5, HTR5A PTPN5 108/4885POLB 3673/4885KDM4E 942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.